Автор: Krishna, Rajesh Название: Biopharmaceutics applications in drug development ISBN: 1441944346 ISBN-13(EAN): 9781441944344 Издательство: Springer Рейтинг: Цена: 30606.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: The highly experienced authors here present readers with step-wise, detail-conscious information to develop quality pharmaceuticals. It provides a specific focus on the integration of regulatory considerations and includes case histories highlighting the biopharmaceutics strategies adopted in development of successful drugs.
Автор: Tansey, Michael Название: Intelligent Drug Development ISBN: 0199974586 ISBN-13(EAN): 9780199974580 Издательство: Oxford Academ Рейтинг: Цена: 9029.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: A guide to making the drug-development process more efficient, by way of analyzing various steps in clinical research.
Автор: Binghe Wang Название: Drug-Drug Interactions in Pharmaceutical Development ISBN: 0471794414 ISBN-13(EAN): 9780471794417 Издательство: Wiley Рейтинг: Цена: 15990.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market.
Описание: Covers the proceedings of `Symposium for future drug discovery and medical care` that intends to exchange ideas how to promote molecular imaging technology and also how to extend the technology to medical therapy and drug development.
Автор: Teicher Название: Anticancer Drug Development Guide. 2ed.2004 ISBN: 1588292282 ISBN-13(EAN): 9781588292285 Издательство: Springer Рейтинг: Цена: 34799.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products. The chapters on phase I, II, and III clinical trials and on novel phase II clinical trial designs for targeted therapies have been significantly updated, along with those on cancer drug development in Europe, working with the NCI, and the FDA's role in cancer drug development and setting requirements for approval.
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru